Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominick J Angiolillo

Showing results (461-470 of 761) with videos related to

Pageof 77
Sort By:
European Heart Journal|June 24, 2008
A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 studyDominick J Angiolillo, Piera Capranzano, Shinya Goto, et al.
Journal of Translational Medicine|April 13, 2018
Clinical implementation of rapid CYP2C19 genotyping to guide antiplatelet therapy after percutaneous coronary interventionLarisa H Cavallari, Francesco Franchi, Fabiana Rollini, et al.
Circulation|April 20, 2011
Randomized trial of atopaxar in the treatment of patients with coronary artery disease: the lessons from antagonizing the cellular effect of Thrombin–Coronary Artery Disease TrialStephen D Wiviott, Marcus D Flather, Michelle L O'Donoghue, et al.
Thrombosis and Haemostasis|October 28, 2016
Impact of chronic kidney disease on platelet P2Y<sub>12</sub> receptor signalling in patients with type 2 diabetes mellitusLydia R Engwenyu, Francesco Franchi, Fabiana Rollini, et al.
Diabetes|October 3, 2008
Vessel shrinkage as a sign of atherosclerosis progression in type 2 diabetes: a serial intravascular ultrasound analysisPilar Jiménez-Quevedo, Nobuaki Suzuki, Cecilia Corros, et al.
Nature Reviews. Cardiology|November 24, 2023
Coronary microvascular obstruction and dysfunction in patients with acute myocardial infarctionMattia Galli, Giampaolo Niccoli, Gianluigi De Maria, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|November 14, 2023
Impact of ethnicity on antiplatelet treatment regimens for bleeding reduction in acute coronary syndromes: a systematic review and pre-specified subgroup meta-analysisMattia Galli, Renzo Laborante, Giovanni Occhipinti, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 6, 2015
Pooled comparison of regadenoson versus adenosine for measuring fractional flow reserve and coronary flow in the catheterization laboratoryJoshua M Stolker, Michael J Lim, David M Shavelle, et al.
Nature Reviews. Cardiology|December 5, 2023
Author Correction: Coronary microvascular obstruction and dysfunction in patients with acute myocardial infarctionMattia Galli, Giampaolo Niccoli, Gianluigi De Maria, et al.
Journal of the American College of Cardiology|April 6, 2016
Reduction in Ischemic Events With Ticagrelor in Diabetic Patients With Prior Myocardial Infarction in PEGASUS-TIMI 54Deepak L Bhatt, Marc P Bonaca, Sameer Bansilal, et al.
Pageof 77

Showing results (461-470 of 761) with videos related to

Sort By:
Pageof 77
European Heart Journal|June 24, 2008
A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 studyDominick J Angiolillo, Piera Capranzano, Shinya Goto, et al.
Journal of Translational Medicine|April 13, 2018
Clinical implementation of rapid CYP2C19 genotyping to guide antiplatelet therapy after percutaneous coronary interventionLarisa H Cavallari, Francesco Franchi, Fabiana Rollini, et al.
Circulation|April 20, 2011
Randomized trial of atopaxar in the treatment of patients with coronary artery disease: the lessons from antagonizing the cellular effect of Thrombin–Coronary Artery Disease TrialStephen D Wiviott, Marcus D Flather, Michelle L O'Donoghue, et al.
Thrombosis and Haemostasis|October 28, 2016
Impact of chronic kidney disease on platelet P2Y<sub>12</sub> receptor signalling in patients with type 2 diabetes mellitusLydia R Engwenyu, Francesco Franchi, Fabiana Rollini, et al.
Diabetes|October 3, 2008
Vessel shrinkage as a sign of atherosclerosis progression in type 2 diabetes: a serial intravascular ultrasound analysisPilar Jiménez-Quevedo, Nobuaki Suzuki, Cecilia Corros, et al.
Nature Reviews. Cardiology|November 24, 2023
Coronary microvascular obstruction and dysfunction in patients with acute myocardial infarctionMattia Galli, Giampaolo Niccoli, Gianluigi De Maria, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|November 14, 2023
Impact of ethnicity on antiplatelet treatment regimens for bleeding reduction in acute coronary syndromes: a systematic review and pre-specified subgroup meta-analysisMattia Galli, Renzo Laborante, Giovanni Occhipinti, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 6, 2015
Pooled comparison of regadenoson versus adenosine for measuring fractional flow reserve and coronary flow in the catheterization laboratoryJoshua M Stolker, Michael J Lim, David M Shavelle, et al.
Nature Reviews. Cardiology|December 5, 2023
Author Correction: Coronary microvascular obstruction and dysfunction in patients with acute myocardial infarctionMattia Galli, Giampaolo Niccoli, Gianluigi De Maria, et al.
Journal of the American College of Cardiology|April 6, 2016
Reduction in Ischemic Events With Ticagrelor in Diabetic Patients With Prior Myocardial Infarction in PEGASUS-TIMI 54Deepak L Bhatt, Marc P Bonaca, Sameer Bansilal, et al.
Pageof 77